SCHEMBL8077198

SCHEMBL8077198

CCCCCCCCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.62
TNF P01375 4/20 0.62
PDE4A P27815 4/20 0.62
PDE4B Q07343 3/20 0.62
PDE4C Q08493 3/20 0.62
PDE4D Q08499 3/20 0.62
CYP1A2 P05177 3/20 0.62
PMP22 Q01453 3/20 0.62
LMNA P02545 2/20 0.62
NFKB1 P19838 2/20 0.62
ACHE P22303 2/20 0.62
USP2 O75604 1/20 0.62
TSHR P16473 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
RXFP1 Q9HBX9 1/20 0.62
ADORA2A P29274 2/20 0.58
BLM P54132 2/20 0.55
ESR1 P03372 1/20 0.55
MAPT P10636 1/20 0.55
CHIT1 Q13231 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6785565 1.00 ADORA2B (0.62) ADORA2BTNFPDE4APDE4BPDE4C
Ammonia Solution, Strong SCHEMBL27840338 0.98 ADORA2B (0.60) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL9293740 0.95 ADORA2B (0.62) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8072448 0.95 ADORA2B (0.62) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL9294827 0.95 ADORA2B (0.62) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8378834 0.94 ADORA2B (0.55) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL6777469 0.93 ADORA2B (0.62) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8015355 0.92 ADORA2B (0.63) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8005651 0.91 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C
SCHEMBL8378556 0.91 ADORA2B (0.54) ADORA2BTNFPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 EP claimed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 EP claimed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 WO claimed
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed